BrandShield Systems reported the removal of 850 rogue online pharmacies and 14,000 fraudulent drug listings over the last year on Friday morning.
The cybersecurity solutions firm worked in partnership with the Pharmaceutical Security Institute from December 2020 to November 2021.
The company reported an estimated $1.8 million of counterfeit deals were removed from the market.
The illegitimate pharmaceuticals were linked to asthma, Covid-19, diabetes, Alzheimer’s and cancer treatments.
Indonesia reported 13,395 marketplace listing removals, with India and the Philippines at 566 and 171.
Malaysia had 135 removals and Singapore recorded 120.
The partnership reportedly used a disruption programme to track down and remove online threats.
It investigated online markets and social media platforms in excess of 100 reported fake listings.
“Criminal fraudsters and scammers posing as reputable pharma companies are a major public health risk for the millions across the globe who are in the market looking for products to treat a range of life-threatening diseases,” said BrandShield CEO Yoav Keren.
“In our work with PSI, we are taking the fight back to not only detect dubious online sellers but also remove these threats as they happen. Such a proactive approach ensures that patients are protected from further harm.”
BrandShield’s share price increased 1.8% to 11.2p in early morning trading on Friday following the company release.